Official LinkedIn page for Esperion. Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines accessible. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.
Community guidelines: https://bit.ly/3vLCGdO
Community guidelines: https://bit.ly/3vLCGdO
Location: United States, Michigan, Ann Arbor
Employees: 201-500
Total raised: $463M
Founded date: 2008
Investors 6
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Alta Partn... | altapartne... |
| - | Asset Mana... | assetman.c... |
| - | Aisling Ca... | aislingcap... |
| - | Longitude ... | longitudec... |
| - | Oak Invest... | oakvc.com |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 03.12.2021 | - | $225M | - |
| 26.06.2019 | - | $200M | - |
| 25.04.2013 | - | $33M | - |
| 17.02.2010 | - | $5M | - |
Mentions in press and media 24
| Date | Title | Description |
| 11.09.2024 | Bridging the Gap: Innovations in Patient Access and Affordability | In the evolving landscape of healthcare, patient access and affordability stand as towering challenges. The journey to obtain medications can feel like navigating a labyrinth. Many patients find themselves lost in a maze of bureaucracy, cos... |
| 09.09.2024 | New Episode of Advancements Airing on Saturday, September 14th at 8:00 pm ET | Advancements broadcast Watch to discover how technology and innovation are beckoning change. JUPITER, Fla., Sept. 9, 2024 /PRNewswire-PRWeb/ -- Tune in to Bloomberg on Saturday, September 14, 2024, to watch a new episode of Advancements, ho... |
| 05.06.2024 | Learn About Improvements in Heart Health on an Upcoming Segment of Advancements | esperion heart health Discover how developments in treatments and medical care are improving patient outcomes. JUPITER, Fla., June 5, 2024 /PRNewswire-PRWeb/ -- Advancements with Ted Danson will explore how innovations in medical trials and... |
| 15.02.2024 | 4 Tips to Get High Cholesterol Under Control | (Family Features) Heart disease is the nation’s leading cause of death for men and women, according to the Centers for Disease Control and Prevention, but many people aren’t aware they may be at elevated risk. More than 71 million adults in... |
| 26.04.2022 | Slone Partners Places Richard B. Bartram as Chief Financial Officer at MBX Biosciences | “Rick Bartram is a tremendously talented and respected business leader with an outstanding track record of success over many years,” said Slone Partners CEO Leslie Loveless. SOUTH RIDING, Va. (PRWEB) April 26, 2022 Slone Partners, a nationw... |
| 08.12.2021 | Esperion Announces Closing of $225 Million Public Offering | ANN ARBOR, Mich., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the closing of its previously announced underwritten public offering of 32,142,858 shares of its common stock and acc... |
| 07.12.2021 | Esperion Announces Closing of $225 Million Public Offering | ANN ARBOR, Mich., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the closing of its previously announced underwritten public offering of 32,142,858 shares of its common stock and acc... |
| 03.12.2021 | Esperion Announces Pricing of $225 Million Public Offering | ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the pricing of its previously announced underwritten public offering of 32,142,858 shares of its common stock and sho... |
| 02.12.2021 | Esperion Announces Pricing of $225 Million Public Offering | ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the pricing of its previously announced underwritten public offering of 32,142,858 shares of its common stock and sho... |
| 25.10.2021 | Esperion Therapeutics : Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock | ANN ARBOR, Mich., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a privately negotiated exchange agreement with two co-managed holders (the “Holders”) of its 4.00% Convertible Senior Subor... |
Show more